ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Dust Mite Allergy
Lung Diseases
Chronic Obstructive Pulmonary Disease
Disease

Asthma trials near Sevilla, AN, ESP:

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 bl...

Active, not recruiting
Asthma (Diagnosis)
Drug: Placebo
Drug: WIN378

Phase 2

Windward Bio

Seville, Sevilla, Spain and 72 other locations

This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...

Active, not recruiting
Asthma
Drug: GSK5784283
Drug: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Seville, Spain and 133 other locations

This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated w...

Enrolling
Eosinophilic Asthma
Combination Product: Placebo for Benralizumab
Combination Product: benralizumab

Phase 3

AstraZeneca
AstraZeneca

Jerez de la Frontera, Spain and 166 other locations

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Enrolling
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Jerez de la Frontera, Cádiz, Spain and 74 other locations

and safety with subcutaneous immunotherapy in patients with mild to moderate rhinitis / rhinoconjunctivitis with or without mild to moderate asthma...

Enrolling
Asthma, Allergic
Rhinoconjunctivitis
Other: Placebo
Biological: 30,000 MG01 + 10,000 T517

Phase 3

Inmunotek

Sevilla, Spain and 31 other locations

This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma...

Enrolling
Eosinophilic Asthma
Drug: KT-621
Other: Placebo

Phase 2

Kymera Therapeutics

Jerez de la Frontera, Spain and 57 other locations

in patients with rhinitis/rhinoconjunctivitis with or without asthma, sensitised to Dermatophagoides pteronyssinus and /or Dermatophagoides ...

Enrolling
Asthma, Allergic
Rhinoconjunctivitis
Biological: 10,000 MM09
Biological: 30,000 MM09

Phase 3

Inmunotek

Sevilla, Spain and 31 other locations

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...

Active, not recruiting
Asthma
Drug: Budesonide/Albuterol
Drug: Lunsekimig

Phase 2

Sanofi
Sanofi

Seville, Spain and 238 other locations

inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...

Active, not recruiting
Asthma
Drug: TEV-56248
Drug: Albuterol sulfate

Phase 3

Teva Branded Pharmaceutical Products R&D LLC

Seville, Spain and 394 other locations

and chronic conditions, including type 1 diabetes (T1D) and asthma. The intervention combines personalized educational content, wearable-dev...

Enrolling
Asthma (Diagnosis)
Asthma Acute
Behavioral: Adhera Caring Digital Program-Obesity (ACDP-O)
Adhera Health

Seville, Spain

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems